» Articles » PMID: 22084692

Venous Thromboembolism: Classification, Risk Factors, Diagnosis, and Management

Overview
Journal ISRN Hematol
Specialty Hematology
Date 2011 Nov 16
PMID 22084692
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Venous thromboembolism (VTE) is categorised as deep venous thrombosis (DVT) and pulmonary embolism (PE). VTE is associated with high morbidity and causes a huge financial burden on patients, hospitals, and governments. Both acquired and hereditary risks factors contribute to VTE. To diagnose VTE, noninvasive cost-effective diagnostic algorithms including clinical probability assessment and D-dimer measurement may be employed followup by compression ultrasonography for suspected DVT patients and multidetector computed tomography angiography for suspected PE patients. There are pharmacological and mechanical interventions to manage and prevent VTE. The pharmacological approaches mainly target pathways in coagulation cascade nonspecifically: conventional anticoagulants or specifically: new generation of anticoagulants. Excess bleeding is one of the major risk factors for pharmacological interventions. Hence, nonpharmacological or mechanical approaches such as inferior vena cava filters, graduated compression stockings, and intermittent pneumatic compression devices in combination with pharmacological interventions or alone may be a good approach to manage VTE.

Citing Articles

Deep vein thrombosis in severe community-acquired pneumonia patients undergoing thromboprophylaxis: Prevalence, risk factors, and outcome.

Cui N, Wang J, Feng X, Zhang L, Yang Y Thromb J. 2025; 23(1):23.

PMID: 40075406 PMC: 11905501. DOI: 10.1186/s12959-025-00706-y.


Emerging Elastic Micro-Nano Materials for Diagnosis and Treatment of Thrombosis.

Lu C, Li C, Gu N, Yang F Research (Wash D C). 2025; 8:0614.

PMID: 40028043 PMC: 11868703. DOI: 10.34133/research.0614.


The Impact of Inferior Vena Cava Anomalies on Deep Vein Thrombosis: A Case Report.

Mansha W, Eftekharzadeh P, Ahmed S Cureus. 2025; 16(12):e75385.

PMID: 39781169 PMC: 11709114. DOI: 10.7759/cureus.75385.


Preoperative risk factors for venous thromboembolism in major urologic cancer surgeries.

Najdi J, Ayoub C, Abou Chawareb E, El Baba B, Malik E, El-Hajj A World J Urol. 2024; 43(1):10.

PMID: 39627453 DOI: 10.1007/s00345-024-05372-9.


Statins for the primary prevention of venous thromboembolism.

Wang Z, Zhang P, Tian J, Zhang P, Yang K, Li L Cochrane Database Syst Rev. 2024; 11:CD014769.

PMID: 39498835 PMC: 11536507. DOI: 10.1002/14651858.CD014769.pub2.


References
1.
Caprini J . Mechanical methods for thrombosis prophylaxis. Clin Appl Thromb Hemost. 2009; 16(6):668-73. DOI: 10.1177/1076029609348645. View

2.
Bounameaux H, Perrier A, Righini M . Diagnosis of venous thromboembolism: an update. Vasc Med. 2010; 15(5):399-406. DOI: 10.1177/1358863X10378788. View

3.
Kearon C . Natural history of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1):I22-30. DOI: 10.1161/01.CIR.0000078464.82671.78. View

4.
Barritt D, Jordan S . Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960; 1(7138):1309-12. DOI: 10.1016/s0140-6736(60)92299-6. View

5.
Penaloza A, Melot C, Motte S . Comparison of the Wells score with the simplified revised Geneva score for assessing pretest probability of pulmonary embolism. Thromb Res. 2010; 127(2):81-4. DOI: 10.1016/j.thromres.2010.10.026. View